Dermatology · Redwood City, CA
NPI
1235457649
Since 2010
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
450 Broadway St Pavilion B
Redwood City, CA, 94063
Phone (650) 721-7194
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
479 services
Medicare patients, 2024
176
Average age 70
Drug cost, 2024
$2.7M
1,507 prescriptions
Company payments, 2025
$52.23
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aruna Venkatesan was code 99214 (office e&m - established), 143 times for 107 patients. In total Aruna Venkatesan billed 479 services in 28 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 143 | 107 | $71.47 | $10K |
| 17003 Destruction Skin Lesion | Facility | 141 | 24 | $1.29 | $182 |
| 17000 Destruction Skin Lesion | Facility | 36 | 29 | $40.26 | $1,450 |
| 11102 Skin Biopsy | Facility | 26 | 26 | $22.63 | $588 |
| 99213 Office E&M - Established | Facility | 25 | 23 | $31.23 | $781 |
| 99203 Office E&M - New | Facility | 21 | 21 | $50.04 | $1,051 |
| 99221 Hospital E&M - Initial | Facility | 13 | 12 | $67.74 | $881 |
By year: 2022 $25K for 574 services; 2023 $22K for 552 services; 2024 $19K for 479 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aruna Venkatesan prescribed most often to Medicare patients was Triamcinolone Acetonide, with 163 prescriptions and refills. In total Aruna Venkatesan wrote 1,507 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 163 | 261 | 76 | $2,928 |
| Dupixent Pen Dupilumab | 155 | 155 | 21 | $573K |
| Ketoconazole Generic | 123 | 136 | 47 | $2,213 |
| Fluocinonide Generic | 78 | 94 | 34 | $2,901 |
| Hydrocortisone Generic | 76 | 79 | 34 | $1,026 |
| Humira Pen Adalimumab | 75 | 75 | 12 | $451K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 66 | 91 | 28 | $3,144 |
| Clobetasol Propionate Generic | 64 | 82 | 25 | $938 |
| Hydroxyzine Hcl Generic | 59 | 74 | 20 | $495 |
| Clotrimazole Generic | 50 | 50 | 13 | $591 |
| Mupirocin Generic | 42 | 42 | 16 | $256 |
| Tacrolimus Generic | 41 | 43 | 17 | $3,642 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 34 | 34 | Under 11 | $251K |
| Humira Adalimumab | 28 | 28 | Under 11 | $357K |
| Acitretin Generic | 27 | 45 | Under 11 | $14K |
Brand drugs: 470 claims; generic drugs: 1,037 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aruna Venkatesan $52.23 ($52.23 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $52.23.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $52.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.